Cumulative exposure to air pollution increases risk of hospitalization for mental and physical illness

The FDA approval of HYMPAVZI was supported by the Phase III BASIS clinical trial. Credit: Andrey_Popov/Shutterstock. Pfizer has announced the approval of HYMPAVZI (marstacimab-hncq) by

In Jan­u­ary, Prax­is priced a $150 mil­lion pub­lic stock of­fer­ing and promised four da­ta read­outs. And on Tues­day morn­ing, the first topline da­ta dropped in